GLP-1 helps to slow digestion and increase satiety, whereas GIP helps enhance insulin secretion and regulate appetite
First-line approaches recommended by NICE and the NHS include: Dietary modification a balanced, calorie-reduced diet tailored to individual needs, with guidance from a registered dietitian where appropriate Increased physical activity at least 150 minutes of moderate-intensity aerobic activity per week for adults, in line with the UK Chief Medical Officers' physical activity guidelines Behavioural interventions cognitive behavioural therapy (CBT)-based programmes, group support, and self-monitoring strategies For individuals with a BMI of 30 kg/m or above (or 27.5 kg/m in certain ethnic groups), pharmacological treatment may be considered alongside lifestyle interventions, subject to clinical assessment and specific eligibility criteria: Orlistat reduces dietary fat absorption and is available via GP prescription
However, nausea is a common side effect of GLP-1s that usually subsides as your body adjusts to the medication
When taken concurrently, these effects may be more pronounced or uncomfortable, potentially affecting your adherence to treatment and overall wellbeing
Can I choose which pharmacy my medication comes from
Retrieved from ncbi
